The increasing incidence of blood disorders and the growth in the number of blood donation are the major factors driving the growth of the global hematology analyzers and reagents market. Technological advancements in hematology analyzers and reagents and the integration of flow cytometry techniques with hematology analyzers are also expected to support the growth of this market during the forecast period.
The report Hematology Analyzers and Reagents Market is projected to reach USD 10.6
billion by 2025 from USD 7.6 billion in 2020, at a CAGR of 6.9% during the
forecast period.
Ask for PDF Brochure: – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153222146
Market Segmentation: -
On the basis of products
& services, the hematology reagents market is classified into hematology,
hemostasis, and immunohematology products & services. The hematology
products & services segment is projected to grow at the highest growth rate
during the forecast period.
By end user, the
hematology analyzers market is segmented into hospital laboratories, commercial
service providers, government reference laboratories, and research &
academic institutes. In 2019, the commercial service providers segment
accounted for the largest share of the market due to factors such as the
increasing awareness about hematology testing, shift from manual testing to
automated testing, and the competitive benefits offered by these providers as
compared to hospitals (such as affordable service costs, efficient turnaround
time, and efficient management of sample collection).
Recent Developments: -
- In
February 2018, Sysmex entered into an agreement with McKesson to
distribute Sysmex’s XW-100 automated hematology analyzers in the US.
- In
September 2017, Sysmex entered into an agreement with Mongolia’s Ministry
of Health to provide technological, scientific, and external quality
assessment support in the field of blood morphology to raise the accuracy
of testing in the Mongolian region.
- Sysmex
expanded its direct sales network in the Republic of Ghana (Africa) to
reinforce its hematology sales and service structure in the African
market.
- In
July 2017, Sysmex launched XN-9100, XN-3100, XN-1500, and SP-50 (an
automated hematology slide preparation unit).
- In
July 2017, Sysmex launched the XN-L automated hematology analyzers in the
US.
Regional Analysis: -
North America accounted
for the largest share of the market in 2019. This can be attributed to the
rising incidence of patients suffering from blood disorders, the growing
prevalence of target diseases, and the rising demand for blood transfusions in
the region.
Request for Sample Pages : – https://www.marketsandmarkets.com/requestsampleNew.asp?id=153222146
Top key Players:-
The major players in the
global hematology reagents market are Sysmex Corporation (Japan), Abbott
Laboratories (US), Danaher Corporation (US), Nihon Kohden (Japan), Siemens
(Germany), Boule Diagnostics (Sweden), HORIBA (Japan), Bio-Rad Laboratories
(US), BioSystems (Spain), Diatron (Hungary), Drew Scientific (US), EKF
Diagnostics (UK), Mindray (China), Ortho Clinical Diagnostics (US), and Roche
(Switzerland).
No comments:
Post a Comment